This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

ValueSet: Aldosterone Antagonists Drug Value Set (Experimental)

Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-AAS				Version: 1.0.0	Highlight text changes?
Standards status: Informative					Computable Name: Valueset_AAS
Copyright/Legal: (copyright expectations unknown)

Value set representing the aldosterone antagonist drug class for PDDI CDS. Membership should be maintained using the documented RxClass/RxMix derivation process rather than a locally enumerated expansion.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

This ValueSet does not have a formal definition; instead, the value set must be prepared by hand using these instructions.

Query NLM RxClass for Aldosterone Antagonists|MOA to identify the class members appropriate for prescribable drug identification. Then use NLM RxMix/RxClass tooling to derive the current RxNorm Semantic Clinical Drug and related prescribable forms needed for implementation.

 

Expansion

---

Description of the above table(s).